114 related articles for article (PubMed ID: 14677515)
1. Production of pilot lots of inactivated influenza vaccine in response to a pandemic threat: an interim biosafety risk assessment.
Wkly Epidemiol Rec; 2003 Nov; 78(47):405-8. PubMed ID: 14677515
[No Abstract] [Full Text] [Related]
2. Influenza. New flu virus in China worries and confuses.
Cohen J
Science; 2013 Apr; 340(6129):129-30. PubMed ID: 23580498
[No Abstract] [Full Text] [Related]
3. Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.
Jadhao SJ; Achenbach J; Swayne DE; Donis R; Cox N; Matsuoka Y
Vaccine; 2008 Mar; 26(14):1742-50. PubMed ID: 18336962
[TBL] [Abstract][Full Text] [Related]
4. Virology. A molecular whodunit.
Webster RG
Science; 2001 Sep; 293(5536):1773-5. PubMed ID: 11546856
[No Abstract] [Full Text] [Related]
5. Attenuation of a human H9N2 influenza virus in mammalian host by reassortment with an avian influenza virus.
Saito T; Lim W; Tashiro M
Arch Virol; 2004 Jul; 149(7):1397-407. PubMed ID: 15221539
[TBL] [Abstract][Full Text] [Related]
6. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
7. Heading off an influenza pandemic.
Holmes EC; Taubenberger JK; Grenfell BT
Science; 2005 Aug; 309(5737):989. PubMed ID: 16099952
[No Abstract] [Full Text] [Related]
8. Antigenic stability of H1N1 pandemic vaccines correlates with vaccine strain.
Farnsworth A; Cyr TD; Li C; Wang J; Li X
Vaccine; 2011 Feb; 29(8):1529-33. PubMed ID: 21211583
[TBL] [Abstract][Full Text] [Related]
9. [High-yield reassortant virus containing hemagglutinin and neuraminidase genes of pandemic influenza A/Moscowl/01/2009 (H1N1) virus].
Ignat'eva AV; Rudneva IA; Timofeeva TA; Shilov AA; Zaberezhnyĭ AD; Aliper TI; Kaverin NV; L'vov DK
Vopr Virusol; 2011; 56(4):9-14. PubMed ID: 21899062
[TBL] [Abstract][Full Text] [Related]
10. Influenza vaccines.
Ellebedy AH; Webby RJ
Vaccine; 2009 Nov; 27 Suppl 4(Suppl 4):D65-8. PubMed ID: 19837290
[TBL] [Abstract][Full Text] [Related]
11. Influenza virus: a master of metamorphosis.
De Jong JC; Rimmelzwaan GF; Fouchier RA; Osterhaus AD
J Infect; 2000 May; 40(3):218-28. PubMed ID: 10908015
[TBL] [Abstract][Full Text] [Related]
12. [Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine].
Kiseleva IV; Voeten JT; Teley LC; Larionova NV; Dubrovina IA; Berdygulova ZhA; Bazhenova EA; van den Bosch H; Heldens JG; Rudenko LG
Mol Gen Mikrobiol Virusol; 2011; (4):29-36. PubMed ID: 22312898
[TBL] [Abstract][Full Text] [Related]
13. Genetic and antigenic relatedness of H3 subtype influenza A viruses isolated from avian and mammalian species.
Yassine HM; Lee CW; Suarez DL; Saif YM
Vaccine; 2008 Feb; 26(7):966-77. PubMed ID: 18206275
[TBL] [Abstract][Full Text] [Related]
14. From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.
Wood JM; Robertson JS
Nat Rev Microbiol; 2004 Oct; 2(10):842-7. PubMed ID: 15378048
[TBL] [Abstract][Full Text] [Related]
15. [The origin of pandemic strains of the influenza A virus].
Golubev DB
Vopr Virusol; 1992; 37(3):130-5. PubMed ID: 1441437
[No Abstract] [Full Text] [Related]
16. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
[TBL] [Abstract][Full Text] [Related]
17. Virology. The origin and control of pandemic influenza.
Laver G; Garman E
Science; 2001 Sep; 293(5536):1776-7. PubMed ID: 11546857
[No Abstract] [Full Text] [Related]
18. [Interspecies transmission of influenza A viruses and influenza pandemics].
Kaverin NV; Smirnov IuA
Vopr Virusol; 2003; 48(3):4-10. PubMed ID: 12894472
[TBL] [Abstract][Full Text] [Related]
19. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
[TBL] [Abstract][Full Text] [Related]
20. Generation and characterization of candidate vaccine viruses for prepandemic influenza vaccines.
O'Neill E; Donis RO
Curr Top Microbiol Immunol; 2009; 333():83-108. PubMed ID: 19768401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
